Ignite Creation Date:
2024-05-06 @ 9:37 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03021213
Status:
WITHDRAWN
Last Update Posted:
2018-04-18
First Post:
2016-10-27
Brief Title:
Treating Heart Failure With Enhanced External Counterpulsation EECP
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Treating Heart Failure With Enhanced External Counterpulsation EECP Prospective Multi-centric Observational Cohort Study
Status:
WITHDRAWN
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Enhanced external counterpulsation EECP is an outpatient coronary artery disease CAD therapy that involves the cyclical inflationdeflation of cuffs wrapped around the lower extremities However the possible benefits of EECP in patients with heart failure HF New York Heart Association NYHA classes II to IV and cardiomyopathy are unclear
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None